Trade Mark Journal No.2026/005 30 January 2026

UK00004325317 16 January 2026 (5)

ATYBRY

Class 5: Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension, interstitial lung disease, and idiopathic pulmonary fibrosis.

United Therapeutics Corporation

Representative: HGF Limited